Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank71
3Y CAGR+66.1%
5Y CAGR-20.0%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

3Y CAGR
+66.1%/yr
vs -2.6%/yr prior
5Y CAGR
-20.0%/yr
Recent acceleration
Acceleration
+68.7pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202517.46%
20243.37%
20236.63%
20223.81%
2021-152.23%
202053.17%
20196.15%
20184.24%
201720.76%
201637.52%